Nezemax (Oxymetazoline Hydrochloride)

Oxymetazoline, the active ingredient in Nezemax, is a alpha‑adrenergic agonist presented as a nasal decongestant for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Nezemax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline is an alpha‑adrenergic agonist used to alleviate nasal congestion in several upper‑respiratory conditions.

- Common cold: reduces nasal blockage and improves airflow. - Sinusitis: decreases mucosal edema to relieve sinus pressure. - Allergic rhinitis: mitigates congestion caused by allergen‑induced inflammation.

Oxymetazoline may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Dryness: dryness of nasal mucosa. - Sneezing: transient sneezing episodes. - Headache: mild headache.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Hypertension: elevated blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heart rhythm in patients with cardiovascular disease. - Nasal ulceration: rare ulcer formation in nasal mucosa.

When using Oxymetazoline, certain precautions should be observed to minimize risks.

- Duration of use: limit to no more than three consecutive days to avoid rebound congestion. - Age restrictions: avoid use in children under six years unless directed by a healthcare professional. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Drug interactions: review concomitant medications, especially monoamine oxidase inhibitors. - Pregnancy and lactation: consult a physician as safety data are limited. - Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Oxymetazoline can interact with certain systemic drugs, altering its effects or increasing adverse events.

Major Interactions (Avoid): - MAO inhibitors: may potentiate hypertensive response. - Sympathomimetic agents: combined use can increase blood pressure.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: may reduce efficacy of blood pressure control. - Tricyclic antidepressants: possible additive cardiovascular effects. - Nasal decongestant sprays: concurrent use can raise risk of rebound congestion.